SFS
SUPN icon

Sowell Financial Services’s Supernus Pharmaceuticals SUPN Stock Holding History

Sowell Financial Services’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-36
Closed -$1K – 2447
2021
Q1 		$1K Sell
36
-402
-92% -$11.2K ﹤0.01% 3015
2020
Q4 		$11K Buy
438
+310
+242% +$6.67K ﹤0.01% 1977
2020
Q3 		$3K Sell
128
-222
-63% -$5.04K ﹤0.01% 2161
2020
Q2 		$8K Sell
350
-1,348
-79% -$29.8K ﹤0.01% 1777
2020
Q1 		$31K Sell
1,698
-1,122
-40% -$23.6K ﹤0.01% 1237
2019
Q4 		$67K Buy
2,820
+2,740
+3,425% +$66.5K 0.01% 1049
2019
Q3 		$2K Buy
+80
New +$2.37K ﹤0.01% 2137

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Sowell Financial Services's SUPN Position: Q2 2021 in Review

Sowell Financial Services sold out of Supernus Pharmaceuticals (SUPN) in Q2 2021, closing a stake of 36 shares — an estimated $1K sold.

Sowell Financial Services first reported a position in SUPN in Q3 2019 and held it in 7 quarters. The position peaked at $67K in Q4 2019. 226 funds tracked by Wall St. Rank hold SUPN as of Q2 2021.

  • Sowell Financial Services reported no remaining Supernus Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 36 Supernus Pharmaceuticals shares in Q2 2021, an estimated $1K.
  • Sowell Financial Services first reported a position in Supernus Pharmaceuticals in Q3 2019 and held it in 7 quarters.
  • Sowell Financial Services's Supernus Pharmaceuticals position peaked at $67K in Q4 2019.
  • 226 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.